Here and Now: Clinical Practice
Reducing the Risk of Vaccine Preventable Diseases During the COVID-19 Pandemic

https://doi.org/10.1016/j.cgh.2020.08.011Get rights and content

Abbreviations used in this paper

COVID-19
coronavirus disease 2019
IBD
inflammatory bowel disease
VPD
vaccine preventable diseases

Cited by (0)

Conflicts of interest These authors disclose the following: Dr Freddy Caldera has received research support from Takeda Pharmaceuticals and Sanofi and has been a consultant for Takeda, Arena Pharmaceuticals, GSK, and Celgene. Dr Farraye is a consultant for BMS, Braintree Labs, Gilead, GSK, Innovation Pharmaceuticals, Janssen, Pfizer, and Sebela and sits on a DSMB for Lilly and Theravance. Dr Hayney is a consultant for GSK Vaccines and Seqirus and has received research support from Takeda Pharmaceuticals and Sanofi. The remaining author discloses no conflicts.

View Abstract